APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Chorionic Gonadotropin (HCG)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Chorionic Gonadotropin (HCG) Industry Growth and Trends Forecast to 2032

22 December 2025110 pages

Choose your research edition.

Industry ResearchHuman Chorionic Gonadotropin (HCG) Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Chorionic Gonadotropin (HCG) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Human Chorionic Gonadotropin (HCG) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Chorionic Gonadotropin (HCG) Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Chorionic Gonadotropin (HCG) Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

According to APO Research, the global Human Chorionic Gonadotropin (HCG) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Chorionic Gonadotropin (HCG) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Chorionic Gonadotropin (HCG) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Chorionic Gonadotropin (HCG) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Human Chorionic Gonadotropin (HCG) market include Sun Pharmaceutical Industries Ltd, Ferring B.V, Fresenius Kabi AG, Zydus Lifesciences Ltd, VHB Medi Sciences Limited, Serum Institute of India Pvt. Ltd, Scripps Laboratories, Sanzyme and Merck & Co., Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Chorionic Gonadotropin (HCG) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Chorionic Gonadotropin (HCG) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Chorionic Gonadotropin (HCG) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Chorionic Gonadotropin (HCG).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Human Chorionic Gonadotropin (HCG) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Chorionic Gonadotropin (HCG) Market by Company

Sun Pharmaceutical Industries Ltd

Ferring B.V

Fresenius Kabi AG

Zydus Lifesciences Ltd

VHB Medi Sciences Limited

Serum Institute of India Pvt. Ltd

Scripps Laboratories

Sanzyme

Merck & Co., Inc

LUPIN

Leebio

Kamiya Biomedical Company

EMD Serono, Inc

Corona Remedies Pvt. Ltd.

Cigna

Bristol Myers Squibb Company

Human Chorionic Gonadotropin (HCG) Segment by Type

Natural Source Extraction

Recombinant DNA Technology

Human Chorionic Gonadotropin (HCG) Segment by Application

Cryptorchidism Treatment

Oligospermic Treatment

Female Infertility Treatment

Others

Human Chorionic Gonadotropin (HCG) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Chorionic Gonadotropin (HCG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Chorionic Gonadotropin (HCG) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Chorionic Gonadotropin (HCG).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Human Chorionic Gonadotropin (HCG) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Human Chorionic Gonadotropin (HCG) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Human Chorionic Gonadotropin (HCG) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Human Chorionic Gonadotropin (HCG) Market Share by Region (2021-2026) Table 4. Global Human Chorionic Gonadotropin (HCG) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Human Chorionic Gonadotropin (HCG) Market Share by Region (2027-2032) Table 6. Global Human Chorionic Gonadotropin (HCG) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Human Chorionic Gonadotropin (HCG) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Human Chorionic Gonadotropin (HCG) Market Size Share by Type (2021-2026) Table 9. Global Human Chorionic Gonadotropin (HCG) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Human Chorionic Gonadotropin (HCG) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Human Chorionic Gonadotropin (HCG) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Human Chorionic Gonadotropin (HCG) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Human Chorionic Gonadotropin (HCG) Market Size Share by Application (2021-2026) Table 24. Global Human Chorionic Gonadotropin (HCG) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Human Chorionic Gonadotropin (HCG) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Human Chorionic Gonadotropin (HCG) Industry Trends Table 37. Human Chorionic Gonadotropin (HCG) Industry Drivers Table 38. Human Chorionic Gonadotropin (HCG) Industry Opportunities and Challenges Table 39. Human Chorionic Gonadotropin (HCG) Industry Restraints Table 40. Global Human Chorionic Gonadotropin (HCG) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Company (2021-2026) Table 42. Global Human Chorionic Gonadotropin (HCG) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Human Chorionic Gonadotropin (HCG) Key Company Headquarters & Area Served Table 44. Global Human Chorionic Gonadotropin (HCG) Company, Product Type & Application Table 45. Global Human Chorionic Gonadotropin (HCG) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Human Chorionic Gonadotropin (HCG) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sun Pharmaceutical Industries Ltd Company Information Table 49. Sun Pharmaceutical Industries Ltd Business Overview Table 50. Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Product Portfolio Table 52. Sun Pharmaceutical Industries Ltd Recent Development Table 53. Ferring B.V Company Information Table 54. Ferring B.V Business Overview Table 55. Ferring B.V Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Ferring B.V Human Chorionic Gonadotropin (HCG) Product Portfolio Table 57. Ferring B.V Recent Development Table 58. Fresenius Kabi AG Company Information Table 59. Fresenius Kabi AG Business Overview Table 60. Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Product Portfolio Table 62. Fresenius Kabi AG Recent Development Table 63. Zydus Lifesciences Ltd Company Information Table 64. Zydus Lifesciences Ltd Business Overview Table 65. Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Product Portfolio Table 67. Zydus Lifesciences Ltd Recent Development Table 68. VHB Medi Sciences Limited Company Information Table 69. VHB Medi Sciences Limited Business Overview Table 70. VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Product Portfolio Table 72. VHB Medi Sciences Limited Recent Development Table 73. Serum Institute of India Pvt. Ltd Company Information Table 74. Serum Institute of India Pvt. Ltd Business Overview Table 75. Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Product Portfolio Table 77. Serum Institute of India Pvt. Ltd Recent Development Table 78. Scripps Laboratories Company Information Table 79. Scripps Laboratories Business Overview Table 80. Scripps Laboratories Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Scripps Laboratories Human Chorionic Gonadotropin (HCG) Product Portfolio Table 82. Scripps Laboratories Recent Development Table 83. Sanzyme Company Information Table 84. Sanzyme Business Overview Table 85. Sanzyme Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sanzyme Human Chorionic Gonadotropin (HCG) Product Portfolio Table 87. Sanzyme Recent Development Table 88. Merck & Co., Inc Company Information Table 89. Merck & Co., Inc Business Overview Table 90. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product Portfolio Table 92. Merck & Co., Inc Recent Development Table 93. LUPIN Company Information Table 94. LUPIN Business Overview Table 95. LUPIN Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. LUPIN Human Chorionic Gonadotropin (HCG) Product Portfolio Table 97. LUPIN Recent Development Table 98. Leebio Company Information Table 99. Leebio Business Overview Table 100. Leebio Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Leebio Human Chorionic Gonadotropin (HCG) Product Portfolio Table 102. Leebio Recent Development Table 103. Kamiya Biomedical Company Company Information Table 104. Kamiya Biomedical Company Business Overview Table 105. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Portfolio Table 107. Kamiya Biomedical Company Recent Development Table 108. EMD Serono, Inc Company Information Table 109. EMD Serono, Inc Business Overview Table 110. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Portfolio Table 112. EMD Serono, Inc Recent Development Table 113. Corona Remedies Pvt. Ltd. Company Information Table 114. Corona Remedies Pvt. Ltd. Business Overview Table 115. Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Product Portfolio Table 117. Corona Remedies Pvt. Ltd. Recent Development Table 118. Cigna Company Information Table 119. Cigna Business Overview Table 120. Cigna Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Cigna Human Chorionic Gonadotropin (HCG) Product Portfolio Table 122. Cigna Recent Development Table 123. Bristol Myers Squibb Company Company Information Table 124. Bristol Myers Squibb Company Business Overview Table 125. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Portfolio Table 127. Bristol Myers Squibb Company Recent Development Table 128. North America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Human Chorionic Gonadotropin (HCG) Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Human Chorionic Gonadotropin (HCG) Market Share by Country (2021-2026) Table 131. North America Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Human Chorionic Gonadotropin (HCG) Market Share Forecast by Country (2027-2032) Table 133. Europe Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Human Chorionic Gonadotropin (HCG) Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Human Chorionic Gonadotropin (HCG) Market Share by Country (2021-2026) Table 136. Europe Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Human Chorionic Gonadotropin (HCG) Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Share by Country (2021-2026) Table 141. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Share Forecast by Country (2027-2032) Table 143. Latin America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Human Chorionic Gonadotropin (HCG) Market Share by Country (2021-2026) Table 146. Latin America Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Human Chorionic Gonadotropin (HCG) Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Share by Country (2021-2026) Table 151. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Human Chorionic Gonadotropin (HCG) Product Image Figure 3. Global Human Chorionic Gonadotropin (HCG) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Human Chorionic Gonadotropin (HCG) Market Size (2021-2032) & (US$ Million) Figure 5. Global Human Chorionic Gonadotropin (HCG) Market Share by Region: 2025 VS 2032 Figure 6. Global Human Chorionic Gonadotropin (HCG) Market Share by Region (2021-2032) Figure 7. North America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Natural Source Extraction Image Figure 13. Global Natural Source Extraction Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Recombinant DNA Technology Image Figure 15. Global Recombinant DNA Technology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Human Chorionic Gonadotropin (HCG) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Human Chorionic Gonadotropin (HCG) Market Share by Type 2025 VS 2032 Figure 18. North America Human Chorionic Gonadotropin (HCG) Market Size Share by Type (2021-2032) Figure 19. Europe Human Chorionic Gonadotropin (HCG) Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Share by Type (2021-2032) Figure 21. Latin America Human Chorionic Gonadotropin (HCG) Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size Share by Type (2021-2032) Figure 23. Cryptorchidism Treatment Image Figure 24. Global Cryptorchidism Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Oligospermic Treatment Image Figure 26. Global Oligospermic Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Female Infertility Treatment Image Figure 28. Global Female Infertility Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Human Chorionic Gonadotropin (HCG) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Human Chorionic Gonadotropin (HCG) Market Share by Application 2025 VS 2032 Figure 33. North America Human Chorionic Gonadotropin (HCG) Market Size Share by Application (2021-2032) Figure 34. Europe Human Chorionic Gonadotropin (HCG) Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Share by Application (2021-2032) Figure 36. Latin America Human Chorionic Gonadotropin (HCG) Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Human Chorionic Gonadotropin (HCG) Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Human Chorionic Gonadotropin (HCG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Human Chorionic Gonadotropin (HCG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Human Chorionic Gonadotropin (HCG) Market Share by Country (2021-2032) Figure 43. Europe Human Chorionic Gonadotropin (HCG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Human Chorionic Gonadotropin (HCG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Human Chorionic Gonadotropin (HCG) Market Share by Country (2021-2032) Figure 46. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Share by Country (2021-2032) Figure 49. Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Human Chorionic Gonadotropin (HCG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Human Chorionic Gonadotropin (HCG) Market Share by Country (2021-2032) Figure 52. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Natural Source Extraction
  • Recombinant DNA Technology
Applications
  • Cryptorchidism Treatment
  • Oligospermic Treatment
  • Female Infertility Treatment
  • Others
Companies covered
  • Sun Pharmaceutical Industries Ltd
  • Ferring B.V
  • Fresenius Kabi AG
  • Zydus Lifesciences Ltd
  • VHB Medi Sciences Limited
  • Serum Institute of India Pvt. Ltd
  • Scripps Laboratories
  • Sanzyme
  • Merck & Co., Inc
  • LUPIN
  • Leebio
  • Kamiya Biomedical Company
  • EMD Serono, Inc
  • Corona Remedies Pvt. Ltd.
  • Cigna
  • Bristol Myers Squibb Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Human Chorionic Gonadotropin (HCG) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Human Chorionic Gonadotropin (HCG) Market Size by Region (2021-2032)
  5. 1.4.1 Global Human Chorionic Gonadotropin (HCG) Market Size by Region (2021-2026)
  6. 1.4.2 Global Human Chorionic Gonadotropin (HCG) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Human Chorionic Gonadotropin (HCG) Market Size (2021-2032)
  8. 1.5.1 North America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2021-2032)
2 Human Chorionic Gonadotropin (HCG) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Natural Source Extraction
  3. 2.1.2 Recombinant DNA Technology
  4. 2.2 Global Human Chorionic Gonadotropin (HCG) Market Size by Type
  5. 2.2.1 Global Human Chorionic Gonadotropin (HCG) Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Human Chorionic Gonadotropin (HCG) Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Human Chorionic Gonadotropin (HCG) Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Human Chorionic Gonadotropin (HCG) Market Size by Regions
  9. 2.3.1 North America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Type (2021-2026)
3 Human Chorionic Gonadotropin (HCG) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cryptorchidism Treatment
  3. 3.1.2 Oligospermic Treatment
  4. 3.1.3 Female Infertility Treatment
  5. 3.1.4 Others
  6. 3.2 Global Human Chorionic Gonadotropin (HCG) Market Size by Application
  7. 3.2.1 Global Human Chorionic Gonadotropin (HCG) Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Human Chorionic Gonadotropin (HCG) Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Human Chorionic Gonadotropin (HCG) Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Human Chorionic Gonadotropin (HCG) Market Size by Regions
  11. 3.3.1 North America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Human Chorionic Gonadotropin (HCG) Industry Trends
  2. 4.2 Human Chorionic Gonadotropin (HCG) Industry Drivers
  3. 4.3 Human Chorionic Gonadotropin (HCG) Industry Opportunities and Challenges
  4. 4.4 Human Chorionic Gonadotropin (HCG) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Human Chorionic Gonadotropin (HCG) Revenue (2021-2026)
  2. 5.2 Global Human Chorionic Gonadotropin (HCG) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Human Chorionic Gonadotropin (HCG) Key Company Headquarters & Area Served
  4. 5.4 Global Human Chorionic Gonadotropin (HCG) Company, Product Type & Application
  5. 5.5 Global Human Chorionic Gonadotropin (HCG) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Human Chorionic Gonadotropin (HCG) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Human Chorionic Gonadotropin (HCG) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Human Chorionic Gonadotropin (HCG) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sun Pharmaceutical Industries Ltd
  2. 6.1.1 Sun Pharmaceutical Industries Ltd Company Information
  3. 6.1.2 Sun Pharmaceutical Industries Ltd Business Overview
  4. 6.1.3 Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Product Portfolio
  6. 6.1.5 Sun Pharmaceutical Industries Ltd Recent Developments
  7. 6.2 Ferring B.V
  8. 6.2.1 Ferring B.V Company Information
  9. 6.2.2 Ferring B.V Business Overview
  10. 6.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Ferring B.V Human Chorionic Gonadotropin (HCG) Product Portfolio
  12. 6.2.5 Ferring B.V Recent Developments
  13. 6.3 Fresenius Kabi AG
  14. 6.3.1 Fresenius Kabi AG Company Information
  15. 6.3.2 Fresenius Kabi AG Business Overview
  16. 6.3.3 Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Product Portfolio
  18. 6.3.5 Fresenius Kabi AG Recent Developments
  19. 6.4 Zydus Lifesciences Ltd
  20. 6.4.1 Zydus Lifesciences Ltd Company Information
  21. 6.4.2 Zydus Lifesciences Ltd Business Overview
  22. 6.4.3 Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Product Portfolio
  24. 6.4.5 Zydus Lifesciences Ltd Recent Developments
  25. 6.5 VHB Medi Sciences Limited
  26. 6.5.1 VHB Medi Sciences Limited Company Information
  27. 6.5.2 VHB Medi Sciences Limited Business Overview
  28. 6.5.3 VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Product Portfolio
  30. 6.5.5 VHB Medi Sciences Limited Recent Developments
  31. 6.6 Serum Institute of India Pvt. Ltd
  32. 6.6.1 Serum Institute of India Pvt. Ltd Company Information
  33. 6.6.2 Serum Institute of India Pvt. Ltd Business Overview
  34. 6.6.3 Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Product Portfolio
  36. 6.6.5 Serum Institute of India Pvt. Ltd Recent Developments
  37. 6.7 Scripps Laboratories
  38. 6.7.1 Scripps Laboratories Company Information
  39. 6.7.2 Scripps Laboratories Business Overview
  40. 6.7.3 Scripps Laboratories Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Scripps Laboratories Human Chorionic Gonadotropin (HCG) Product Portfolio
  42. 6.7.5 Scripps Laboratories Recent Developments
  43. 6.8 Sanzyme
  44. 6.8.1 Sanzyme Company Information
  45. 6.8.2 Sanzyme Business Overview
  46. 6.8.3 Sanzyme Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sanzyme Human Chorionic Gonadotropin (HCG) Product Portfolio
  48. 6.8.5 Sanzyme Recent Developments
  49. 6.9 Merck & Co., Inc
  50. 6.9.1 Merck & Co., Inc Company Information
  51. 6.9.2 Merck & Co., Inc Business Overview
  52. 6.9.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product Portfolio
  54. 6.9.5 Merck & Co., Inc Recent Developments
  55. 6.10 LUPIN
  56. 6.10.1 LUPIN Company Information
  57. 6.10.2 LUPIN Business Overview
  58. 6.10.3 LUPIN Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 LUPIN Human Chorionic Gonadotropin (HCG) Product Portfolio
  60. 6.10.5 LUPIN Recent Developments
  61. 6.11 Leebio
  62. 6.11.1 Leebio Company Information
  63. 6.11.2 Leebio Business Overview
  64. 6.11.3 Leebio Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Leebio Human Chorionic Gonadotropin (HCG) Product Portfolio
  66. 6.11.5 Leebio Recent Developments
  67. 6.12 Kamiya Biomedical Company
  68. 6.12.1 Kamiya Biomedical Company Company Information
  69. 6.12.2 Kamiya Biomedical Company Business Overview
  70. 6.12.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Portfolio
  72. 6.12.5 Kamiya Biomedical Company Recent Developments
  73. 6.13 EMD Serono, Inc
  74. 6.13.1 EMD Serono, Inc Company Information
  75. 6.13.2 EMD Serono, Inc Business Overview
  76. 6.13.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Portfolio
  78. 6.13.5 EMD Serono, Inc Recent Developments
  79. 6.14 Corona Remedies Pvt. Ltd.
  80. 6.14.1 Corona Remedies Pvt. Ltd. Company Information
  81. 6.14.2 Corona Remedies Pvt. Ltd. Business Overview
  82. 6.14.3 Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Product Portfolio
  84. 6.14.5 Corona Remedies Pvt. Ltd. Recent Developments
  85. 6.15 Cigna
  86. 6.15.1 Cigna Company Information
  87. 6.15.2 Cigna Business Overview
  88. 6.15.3 Cigna Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Cigna Human Chorionic Gonadotropin (HCG) Product Portfolio
  90. 6.15.5 Cigna Recent Developments
  91. 6.16 Bristol Myers Squibb Company
  92. 6.16.1 Bristol Myers Squibb Company Company Information
  93. 6.16.2 Bristol Myers Squibb Company Business Overview
  94. 6.16.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Portfolio
  96. 6.16.5 Bristol Myers Squibb Company Recent Developments
7 North America
  1. 7.1 North America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Human Chorionic Gonadotropin (HCG) Market Size by Country (2021-2026)
  3. 7.3 North America Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Human Chorionic Gonadotropin (HCG) Market Size by Country (2021-2026)
  3. 8.3 Europe Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Human Chorionic Gonadotropin (HCG) Market Size by Country (2021-2026)
  3. 10.3 South America Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst